Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma
Shanghai Jiao Tong University School of Medicine
Shanghai Jiao Tong University School of Medicine
Thomas Jefferson University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Prescient Therapeutics, Ltd.
Memorial Sloan Kettering Cancer Center
Assistance Publique - Hôpitaux de Paris
Washington University School of Medicine
City of Hope Medical Center
UNC Lineberger Comprehensive Cancer Center
University of Pittsburgh
University of Pittsburgh
Fondazione Italiana Linfomi - ETS
Fondazione Italiana Linfomi - ETS
UNC Lineberger Comprehensive Cancer Center
National Cancer Institute (NCI)
City of Hope Medical Center
Assistance Publique - Hôpitaux de Paris
Kyowa Kirin Co., Ltd.
SciTech Development, Inc.
Kyowa Kirin Co., Ltd.
City of Hope Medical Center
City of Hope Medical Center
Mayo Clinic
Icahn School of Medicine at Mount Sinai
Barbara Ann Karmanos Cancer Institute
Stanford University
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Thomas Jefferson University
Instituto de Investigación Biomédica de Salamanca
Washington University School of Medicine